JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CERAMI, A.
Right arrow Articles by GILLETTE, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CERAMI, A.
Right arrow Articles by GILLETTE, P. N.
Journal of Pharmacology And Experimental Therapeutics, Vol. 185, Issue 3, 653-666, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


PHARMACOLOGY OF CYANATE. I. GENERAL EFFECTS ON EXPERIMENTAL ANIMALS

A. CERAMI 1, T. A. ALLEN 1, J. H. GRAZIANO 1, F. G. deFURIA 1, J. M. MANNING 1, and P. N. GILLETTE 1

1 The Rockefeller University, New York and the Departments of Pediatirics and Medicine, Cornell University Medical College, New York, New York

The development of cyanate as an antisicklimg drug in the treatment of sickle cell disease necessitated an investigation of its effect on experimental animals. The LD30 for a single i.P. injection of NaNCO and KNCO 260 and 320 mg/kg, respectively. The i.p. injection of KNCO (32 mg/kg) to mice once daily (five times a week) for a five-month period had no adverse effects. In addition, sodium cyanate was administered orally to dogs (100 mg/kg of NaNCO) and monkeys (100 mg/kg of NaNCO) for a 15-month period without any apparent ill effects being observed. In fact, the only measurable difference between the control animals and the animals receiving cyanate was an increase in the oxygen affinity of the blood of all the species receiving cyanate. Although this change in the P50, of the blood is quite dranmatic, no physiological or pathological sequelae have been observed in animals receiving cyanate. The specificity of the cyanate for the NH2-terminal valine of hemoglobin is quite striking. Continuous cyanate administration leads to an accumulation of sim1 carbamyl group per hemoglobin tetramer with no measurable carbamylation of the egr-amino groups of lysine residues of hemoglobin. The injection of 10 µmol of 14C-cyanate to a mouse Produced the following distribution of radioactivity : 72% broken down to CO2, 7% in the urine, 7.5% as a specific carbamylation of the NH2-terminal valine of hemoglobin, 3.3% in bones. 2.1% in muscle, and less than 3% in all the other organs. The chronic administration of cyanate leads to an accumulation of carbamyl groups on the hemoglobin and in other organs although the number of carbamyl groups in all the various compartments eventually plateaus after different periods of time. The similarity in structure and reactivity of CO2 and cyanate probably accounts for the specificity of cyanate for the NH2-terminal valine of hemoglobin. It is thus possible to achieve sim1 carbamyl group per hemoglobin tetramer without seriously affecting the well-being of the species studied.

Submitted on October 23, 1972
Accepted on January 5, 1973




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
K. K. Henderson, W. McCanse, T. Urano, I. Kuwahira, R. Clancy, and N. C. Gonzalez
Acute vs. chronic effects of elevated hemoglobin O2 affinity on O2 transport in maximal exercise
J Appl Physiol, July 1, 2000; 89(1): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. McCanse, K. Henderson, T. Urano, I. Kuwahira, R. L. Clancy, and N. C. Gonzalez
Effect of chronic sodium cyanate administration on O2 transport and uptake in hypoxic and normoxic exercise
J Appl Physiol, April 1, 1999; 86(4): 1257 - 1263.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.